Number of the records: 1
CBD is not converted to THC in rats: A framework interpretation and discussion.
- 1.
SYSNO ASEP 0550036 Document Type O - Others R&D Document Type O - Ostatní Title CBD is not converted to THC in rats: A framework interpretation and discussion. Author(s) Vacek, J. (CZ)
Papoušková, B. (CZ)
Polanská, H. (CZ)
Hönigová, K. (CZ)
Storch, Jan (UCHP-M) RID, ORCID, SAI
Babula, P. (CZ)
Masařík, M. (CZ)Year of issue 2021 Source Title European Neuropsychopharmacology. - : Elsevier - ISSN 0924-977X
Roč. 50, SEP 2021 (2021), s. 135-136Number of pages 2 s. Language eng - English Country NL - Netherlands Keywords cannabidiol ; dronabinol ; biotransformation Subject RIV CE - Biochemistry OECD category Biochemistry and molecular biology Method of publishing Open access with time embargo (01.10.2022) Institutional support UCHP-M - RVO:67985858 UT WOS 000688393100016 EID SCOPUS 85107021577 DOI 10.1016/j.euroneuro.2021.04.003 Annotation Cannabidiol (CBD) is a non-psychotropic exogenous cannabinoid that is an active component in a number of topical and oral preparations. The pharmacological potential of CBD is determined by its anti-inflammatory and immuno- or neuromodulatory activities. This natural terpenoid is widely used today, and therefore more attention is now paid to examining its safety after the administration of high doses (Epidiolex) and also after low-dose chronic exposure, e.g. in the form of food supplements. CBD is therefore a molecule that has recently gained a great deal of scientific interest, both at the level of basic research and industrial development. Workplace Institute of Chemical Process Fundamentals Contact Eva Jirsová, jirsova@icpf.cas.cz, Tel.: 220 390 227 Year of Publishing 2022 Electronic address http://hdl.handle.net/11104/0325893
Number of the records: 1